171 related articles for article (PubMed ID: 30296542)
1. Predictors of mucosal melanoma survival in a population-based setting.
Altieri L; Eguchi M; Peng DH; Cockburn M
J Am Acad Dermatol; 2019 Jul; 81(1):136-142.e2. PubMed ID: 30296542
[TBL] [Abstract][Full Text] [Related]
2. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
3. Poor prognosis for thin ulcerated melanomas and implications for a more aggressive approach to treatment.
Hawkins ML; Rioth MJ; Eguchi MM; Cockburn M
J Am Acad Dermatol; 2019 Jun; 80(6):1640-1649. PubMed ID: 30654077
[TBL] [Abstract][Full Text] [Related]
4. Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.
Luen S; Wong SW; Mar V; Kelly JW; McLean C; McArthur GA; Haydon A
Am J Clin Oncol; 2018 Jan; 41(1):90-94. PubMed ID: 26325493
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in patients with mucosal melanomas.
Keller DS; Thomay AA; Gaughan J; Olszanski A; Wu H; Berger AC; Farma JM
J Surg Oncol; 2013 Dec; 108(8):516-20. PubMed ID: 24132665
[TBL] [Abstract][Full Text] [Related]
6. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
7. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.
Lachiewicz AM; Berwick M; Wiggins CL; Thomas NE
Arch Dermatol; 2008 Apr; 144(4):515-21. PubMed ID: 18427046
[TBL] [Abstract][Full Text] [Related]
8. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of S100/CD31 and S100/podoplanin double immunostaining in mucosal malignant melanoma of the head and neck.
Wermker K; Brauckmann T; Klein M; Haßfeld S; Schulze HJ; Hallermann C
Head Neck; 2015 Sep; 37(9):1368-74. PubMed ID: 24817089
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and incidence of primary mucosal melanoma: a population-based study in France.
Beaudoux O; Riffaud L; Barbe C; Grange F
Eur J Dermatol; 2018 Oct; 28(5):654-660. PubMed ID: 30378540
[TBL] [Abstract][Full Text] [Related]
11. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
12. Lethal Melanomas: A Population-based Registry Study in Western Sweden from 1990 to 2014.
Claeson M; Gillstedt M; Whiteman DC; Paoli J
Acta Derm Venereol; 2017 Nov; 97(10):1206-1211. PubMed ID: 28761961
[TBL] [Abstract][Full Text] [Related]
13. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
[TBL] [Abstract][Full Text] [Related]
15. The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival.
Fortes C; Mastroeni S; Caggiati A; Passarelli F; Zappalà A; Capuano M; Bono R; Nudo M; Marino C; Michelozzi P
Am J Surg; 2016 Nov; 212(5):935-940. PubMed ID: 27266393
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
17. Nail apparatus melanoma: A comparative, clinicoprognostic study of the initial clinical and morphological characteristics of 49 patients.
Lee WJ; Lee JH; Won CH; Chang SE; Choi JH; Moon KC; Lee MW
J Am Acad Dermatol; 2015 Aug; 73(2):213-20. PubMed ID: 26028523
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China.
Hao M; Zhao G; Du X; Yang Y; Yang J
Tumour Biol; 2016 Aug; 37(8):10339-48. PubMed ID: 26846098
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of 39 cases of pediatric cutaneous head and neck melanoma.
Tcheung WJ; Marcello JE; Puri PK; Abernethy AP; Nelson KC
J Am Acad Dermatol; 2011 Aug; 65(2):e37-e42. PubMed ID: 21075477
[TBL] [Abstract][Full Text] [Related]
20. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
